|| Posmeal MD
What is Posmeal MD?
Posmeal MD (Voglibose) is an alpha-glycosidase inhibitor, which is used to reduce postprandial blood glucose levels in patients with diabetes. Posmeal MD (Voglibose) suppresses glucose absorption, decreasing the risks of macrovascular complications. Postprandial hyperglycemia is related to the first phase of insulin secretion. Alpha-glycosidase inhibitors suppress glucose absorption in the intestines, preventing the increase in postprandial glucose level. This class of medications comprises three substances: Acarbose, Miglitol, and Voglibose. Voglibose is the most recently developed medication in this class. Potentially, Voglibose may cause more side effects that Acarbose and Miglitol, but it is also more effective. A number of studies have been conducted to back up Voglibose use for postprandial hyperglycemia. The studies have also shown that postprandial hyperglycemia is the marker of diabetes-related cardiovascular disorders.
How is Posmeal MD used?
The dosage of Posmeal MD (Voglibose) prescribed to each patient will vary. Always follow your physician's instructions and/or the directions on the prescription drug label.
Posmeal MD (Voglibose) is available in dosages of 0.2 and 0.3 mg and administered orally three times daily immediately before each meal. In elderly patients, it is recommended to initiate the treatment at lower doses.
Like other medicines, Posmeal MD (Voglibose) can cause side effects. If they do occur, the side effects of Posmeal MD (Voglibose) will most likely be minor and temporary. However, some side effects may be serious and may require the patient to contact the physician or seek medical attention at the nearest hospital immediately.
Posmeal MD (Voglibose) side effects cannot be anticipated. If any side effects develop or change in intensity, make sure to inform your physician as soon as possible.
Posmeal MD (Voglibose) can cause side effects such as diarrhea, flatulence, skin reactions, and hypoglycemia. This is not a complete list of all side effects. Make sure to consult with your physician and follow all directions when taking Posmeal MD (Voglibose).
Posmeal MD (Voglibose) may enhance effects of other antidiabetics including insulin.
Posmeal MD (Voglibose) is contraindicated in patients suffering from inflammatory bowel disease; gastrointestinal obstruction, as well as in patients predisposed to it; conditions which may deteriorate as a result of increased gas formation, such as hernia; severe ketosis; diabetic coma or pre-coma; severe infection; hypersensitivity; pregnancy; lactation.
Caution has to be exercised when prescribing Posmeal MD (Voglibose) to patients with laparotomy or ileus in past medical history and Roemheld's syndrome, severe hepatic or renal impairment, and stenosis in the current medical history.
Any medication taken in excess can have serious consequences. If an overdose of Posmeal MD (Voglibose) is suspected, please seek medical attention immediately.